Characterization of COVID-19 disease in pediatric oncology patients: The New York-New Jersey regional experience.

P Pallavi MadhusoodhanJoanna PierroJordan MusantePrachi KothariBradley GampelBurton AppelAdam LevyAdit L TalLaura HoganArchana SharmaShari FeinbergAlissa KahnAshley PinchinatTeena BhatlaChana L GlasserPrakash SatwaniElizabeth A RaetzKenan OnelWilliam L Carroll

Published in: Pediatric blood & cancer (2020)

In this large multi-institutional cohort, we observed that mortality and morbidity from COVID-19 amongst pediatric oncology patients were low overall, but higher than reported in general pediatrics. Certain subgroups might be at higher risk of severe disease. Delays in cancer care due to SARS-CoV-2 remain a concern.

Keyphrases

sars cov
end stage renal disease
ejection fraction
coronavirus disease
newly diagnosed
chronic kidney disease
palliative care
type diabetes
respiratory syndrome coronavirus
coronary artery disease
cardiovascular events
young adults
patient reported
drug induced